Compare StocksCME vs MS

CME Group Inc. (CME) vs Morgan Stanley (MS): Which Is the Better Buy in 2026?

As of 2026-06-19, CME is overvalued at $246, with a DCF intrinsic value of $218 and a margin of safety of -13%. MS is undervalued at $223, with an intrinsic value of $298 and a margin of safety of 25%. Of the two, MS has the wider margin of safety.

CME
CME Group Inc.
$246.38
VS
MS
Morgan Stanley
$223.17

Rewards

CME
  • Gross margin of 100.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • CME Group Inc. scores 77/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Free cash flow has grown at a 12.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
MS
  • Gross margin of 87.4% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Morgan Stanley scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Each dollar of retained earnings has created $3.56 of earning power — management is an exceptional capital allocator.

Risks

CME
  • PEG ratio of 4.59 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.53 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
MS
  • Trailing P/E of 20.2x is 26% above the historical average of 16.1x — the stock trades at a premium to its own history.
  • PEG ratio of 2.66 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.29 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
CME
MS
Valuation
$4.19B
Free Cash Flow
N/A
4.71%
FCF Yield
N/A
21.41
Trailing P/E
20.21
19.07
Forward P/E
17.56
Quality & Moat
12.25%
ROIC
3.38%
15.92%
ROE
16.39%
100.00%
Gross Margin
87.39%
4.59
PEG Ratio
2.66
Balance Sheet Safety
0.05
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
0.26
Net Debt / EBITDA
N/A
1.99%
Dividend Yield
1.81%
CME: 3Ties: 2MS: 4
CMEMS

Historical Fundamentals

Learn more →
CME

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

MS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
CME
$526.78
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$71.5M
Δ Market Cap
+$37.66B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
MS
$6.65
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$20.84B
Δ Market Cap
+$138.59B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CME
12.9% Overvalued
Price is 12.9% above estimated fair value
Current Price: $246.38
Fair Value: $218.17
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
MS
25.0% Margin of Safety
Price is 25.0% below estimated fair value
Current Price: $223.17
Fair Value: $297.53
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CME

What growth rate is the market pricing in at $246?

+8.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +8.3% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +8.7%, reflecting heavy growth investment expected to generate future returns.

MS

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
CME
77/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by margin stability. ROIC Consistency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
MS
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
CME
-2.43
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
MS
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CME
Insiders 0.4%Institutions 92.7%Retail & Other 6.9%
No. of Institutional Holders2,391
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
MS
Insiders 24.3%Institutions 62.8%Retail & Other 12.9%
No. of Institutional Holders3,208
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CME
1
Buys (3M)
2
Buys (12M)
Total value (12M): $509,437
SHEPARD WILLIAM R
Director
$437,101
@ $297.55 · 2026-03-26
SHEPARD WILLIAM R
Director
$72,336
@ $270.92 · 2025-06-25
SHEPARD WILLIAM R
Director
$71,995
@ $262.76 · 2025-03-26
SHEPARD WILLIAM R
Director
$325,798
@ $227.99 · 2025-01-16
SHEPARD WILLIAM R
Director
$324,198
@ $227.99 · 2025-01-16
BENESH KATHRYN
Director
$3,595
@ $239.67 · 2024-12-27
SHEPARD WILLIAM R
Director
$63,945
@ $218.99 · 2024-09-25
Open market purchases · includes direct & indirect ownership · excludes option exercises
MS
0
Buys (3M)
1
Buys (12M)
Total value (12M): $5,630
PETERSON DOUGLAS L
Director
$5,630
@ $156.39 · 2025-10-17
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CME
2
Sells (3M)
14
Sells (12M)
Total value (12M): $28.07M
PIELL HILDA HARRIS
Officer
$1.75M
@ $304.63 · 2026-05-18
DUFFY TERRENCE A
Chief Executive Officer
$10.45M
@ $298.51 · 2026-05-15
MARCUS JONATHAN L
General Counsel
$1.10M
@ $333.37 · 2026-03-17
MARCUS JONATHAN L
Officer
$1.03M
@ $313.37 · 2026-03-17
VROMAN KENDAL L
Officer
$1.59M
@ $309.00 · 2026-03-12
DURKIN BRYAN T
Director
$1.30M
@ $309.65 · 2026-02-23
GEPSMAN MARTIN J
Director
$91,770
@ $305.90 · 2026-02-20
SUSKIND DENNIS A
Director
$224,400
@ $300.00 · 2026-02-06
DUFFY TERRENCE A
Chief Executive Officer
$6.74M
@ $269.55 · 2025-12-11
FORD HAROLD EUGENE JR
Director
$263,530
@ $263.53 · 2025-11-03
MARCUS JONATHAN L
General Counsel
$102,704
@ $262.00 · 2025-09-18
MCCOURT TIMOTHY FRANCIS
Officer
$98,476
@ $259.83 · 2025-09-16
MARCUS JONATHAN L
General Counsel
$97,369
@ $258.96 · 2025-09-16
CUTINHO SUNIL KIRAN
Chief Technology Officer
$3.23M
@ $271.47 · 2025-08-26
KAYE DANIEL G
Director
$141,210
@ $282.42 · 2025-05-22
MARCUS JONATHAN L
General Counsel
$108,225
@ $277.50 · 2025-05-20
LOCKETT PHYLLIS M
Director
$294,553
@ $277.88 · 2025-05-19
GEPSMAN MARTIN J
Director
$81,951
@ $273.17 · 2025-05-15
SUSKIND DENNIS A
Director
$271,280
@ $271.28 · 2025-04-29
GERDES LARRY G
Director
$1.06M
@ $265.11 · 2025-04-25
LUCAS DEBORAH J
Director
$385,425
@ $256.95 · 2025-03-14
DUFFY TERRENCE A
Chief Executive Officer
$7.78M
@ $259.18 · 2025-03-11
SPRAGUE SUZANNE
Chief Operating Officer
$385,249
@ $256.83 · 2025-03-03
PIELL HILDA HARRIS
Officer
$997,853
@ $250.47 · 2025-02-27
WINKLER JULIE
Officer
$2.89M
@ $249.17 · 2025-02-13
VROMAN KENDAL L
Officer
$1.27M
@ $250.00 · 2025-02-13
GEPSMAN MARTIN J
Director
$89,168
@ $222.92 · 2024-11-04
CUTINHO SUNIL KIRAN
Chief Technology Officer
$1.02M
@ $226.64 · 2024-10-30
BITSBERGER TIMOTHY S
Director
$226,957
@ $226.96 · 2024-10-30
MCCOURT TIMOTHY FRANCIS
Officer
$312,056
@ $227.11 · 2024-10-28
FITZPATRICK LYNNE
Chief Financial Officer
$163,610
@ $216.99 · 2024-09-13
DURKIN BRYAN T
Director
$1.63M
@ $214.59 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
MS
4
Sells (3M)
16
Sells (12M)
Total value (12M): $70.42M
GROSSMAN ERIC F
Officer
$2.12M
@ $190.75 · 2026-04-20
SIMKOWITZ DANIEL A
President
$2.78M
@ $189.24 · 2026-04-17
CRAWLEY MANDELL L.
Officer
$3.04M
@ $188.22 · 2026-04-16
SAPERSTEIN ANDREW MICHAEL
President
$9.74M
@ $188.59 · 2026-04-16
SIMKOWITZ DANIEL A
President
$6.02M
@ $182.61 · 2026-01-30
CRAWLEY MANDELL L.
Officer
$1.44M
@ $183.45 · 2026-01-20
YESHAYA SHARON
Chief Financial Officer
$2.94M
@ $185.77 · 2026-01-20
SMITH CHARLES AUBREY III
Officer
$1.55M
@ $182.08 · 2026-01-20
SAPERSTEIN ANDREW MICHAEL
President
$5.57M
@ $183.62 · 2026-01-20
GROSSMAN ERIC F
Officer
$3.97M
@ $184.00 · 2026-01-20
PIZZI MICHAEL A
Officer
$3.69M
@ $184.55 · 2026-01-20
PICK EDWARD N.
Chief Executive Officer
$16.43M
@ $164.34 · 2025-10-31
SMITH CHARLES AUBREY III
Officer
$2.81M
@ $140.30 · 2025-07-17
SIMKOWITZ DANIEL A
President
$4.09M
@ $141.13 · 2025-07-17
GROSSMAN ERIC F
Officer
$1.69M
@ $141.12 · 2025-07-17
PIZZI MICHAEL A
Officer
$2.53M
@ $140.62 · 2025-07-17
SIMKOWITZ DANIEL A
President
$3.70M
@ $127.37 · 2025-05-12
HERZ ROBERT H
Director
$95,459
@ $119.32 · 2025-05-02
SAPERSTEIN ANDREW MICHAEL
President
$4.80M
@ $120.00 · 2025-05-02
GROSSMAN ERIC F
Officer
$1.12M
@ $111.65 · 2025-04-15
CRAWLEY MANDELL L.
Officer
$1.15M
@ $138.06 · 2025-01-22
SAPERSTEIN ANDREW MICHAEL
President
$4.20M
@ $136.43 · 2025-01-21
SIMKOWITZ DANIEL A
President
$5.00M
@ $136.61 · 2025-01-21
AKRAM RAJA
Chief Financial Officer
$2.38M
@ $136.01 · 2025-01-21
GROSSMAN ERIC F
Officer
$1.78M
@ $136.20 · 2025-01-21
PIZZI MICHAEL A
Officer
$2.52M
@ $136.92 · 2025-01-21
CRAWLEY MANDELL L.
Officer
$368,375
@ $105.25 · 2024-07-26
AKRAM RAJA
Officer
$797,764
@ $106.37 · 2024-07-18
HERZ ROBERT H
Director
$106,621
@ $106.62 · 2024-07-17
SIMKOWITZ DANIEL A
President
$4.26M
@ $106.54 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CME
FearGreed
😨Fear(32/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
MS
FearGreed
😏Greed(70/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CME
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (32)
MS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (70)
View CME Full AnalysisView MS Full Analysis

Frequently Asked Questions: CME vs MS

Is CME Group Inc. or Morgan Stanley more undervalued in 2026?

Based on our discounted cash flow model, MS trades at a 25.0% margin of safety (intrinsic value $298 vs. price $223), compared to CME's -12.9% margin of safety (intrinsic $218 vs. $246).

Which stock has a wider economic moat, CME Group Inc. or Morgan Stanley?

MS scores 80/100 (Wide moat), while CME scores 77/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Morgan Stanley in financial distress?

MS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. CME scores 0.5 (Distress zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, CME Group Inc. or Morgan Stanley?

CME earns 12.2% ROIC versus MS's 3.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, CME Group Inc.'s or Morgan Stanley's?

MS's dividend earns a safety score of 79/100 (Safe), compared to CME's 34/100 (Unsafe). MS has raised its dividend for 3 consecutive years.